FDA places stricter limits on J&J’s COVID-19 vaccine after review of rare side effect

The agency is limiting use to adults who either can’t or won’t take another authorized vaccine after collecting more data on a rare and unusual clotting syndrome that has weighed on the shot’s uptake.